-
1
-
-
4344668661
-
Drug repositioning: identifying and developing new uses for existing drugs
-
Ashburn TT and Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004; 3: 673-683.
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 673-683
-
-
Ashburn, T.T.1
Thor, K.B.2
-
2
-
-
35248826388
-
Old drugs-new uses
-
Aronson JK. Old drugs-new uses. Br J Clin Pharmacol 2007; 64: 563-565.
-
(2007)
Br J Clin Pharmacol
, vol.64
, pp. 563-565
-
-
Aronson, J.K.1
-
3
-
-
34547770279
-
New uses for old drugs
-
Chong CR and Sullivan DJ Jr. New uses for old drugs. Nature 2007; 448: 645-646.
-
(2007)
Nature
, vol.448
, pp. 645-646
-
-
Chong, C.R.1
Sullivan, D.J.2
-
4
-
-
84871344600
-
Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults
-
Cartagena A, Prasad AN, Rupar CA, Strong M, Tuchman M, Ah Mew N and Prasad C. Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults. Can J Neurol Sci 2013; 40: 3-9.
-
(2013)
Can J Neurol Sci
, vol.40
, pp. 3-9
-
-
Cartagena, A.1
Prasad, A.N.2
Rupar, C.A.3
Strong, M.4
Tuchman, M.5
Ah Mew, N.6
Prasad, C.7
-
5
-
-
84862076431
-
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
-
Haberle J. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency. Ther Clin Risk Manag 2011; 7: 327-332.
-
(2011)
Ther Clin Risk Manag
, vol.7
, pp. 327-332
-
-
Haberle, J.1
-
6
-
-
84897366987
-
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
-
Daniotti M, la Marca G, Fiorini P and Filippi L. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Int J Gen Med 2011; 4: 21-28.
-
(2011)
Int J Gen Med
, vol.4
, pp. 21-28
-
-
Daniotti, M.1
la Marca, G.2
Fiorini, P.3
Filippi, L.4
-
7
-
-
84875626723
-
Inborn errors of metabolism in adult neurology]
-
Sedel F. [Inborn errors of metabolism in adult neurology]. Rev Neurol (Paris) 2013; 169 Suppl 1: S63-69.
-
(2013)
Rev Neurol (Paris
, vol.169
, pp. S63-69
-
-
Sedel, F.1
-
9
-
-
84862094363
-
N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment
-
Ah Mew N and Caldovic L. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment. Appl Clin Genet 2011; 4: 127-135.
-
(2011)
Appl Clin Genet
, vol.4
, pp. 127-135
-
-
Ah Mew, N.1
Caldovic, L.2
-
10
-
-
78649321933
-
Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency
-
Martinez AI, Perez-Arellano I, Pekkala S, Barcelona B and Cervera J. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab 2010; 101: 311-323.
-
(2010)
Mol Genet Metab
, vol.101
, pp. 311-323
-
-
Martinez, A.I.1
Perez-Arellano, I.2
Pekkala, S.3
Barcelona, B.4
Cervera, J.5
-
11
-
-
1642465541
-
Problems in the management of urea cycle disorders
-
Wilcken B. Problems in the management of urea cycle disorders. Mol Genet Metab 2004; 81 Suppl 1: S86-91.
-
(2004)
Mol Genet Metab
, vol.81
, pp. S86-91
-
-
Wilcken, B.1
-
12
-
-
80052712639
-
Clinical and experimental applications of sodium phenylbutyrate
-
Iannitti T and Palmieri B. Clinical and experimental applications of sodium phenylbutyrate. Drugs R D 2011; 11: 227-249.
-
(2011)
Drugs R D
, vol.11
, pp. 227-249
-
-
Iannitti, T.1
Palmieri, B.2
-
13
-
-
21744459301
-
Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway
-
Zhang X, Wei L, Yang Y and Yu Q. Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway. J Cell Biochem 2004; 93: 819-829.
-
(2004)
J Cell Biochem
, vol.93
, pp. 819-829
-
-
Zhang, X.1
Wei, L.2
Yang, Y.3
Yu, Q.4
-
14
-
-
0036825188
-
Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug
-
Shi MG, Huang Q, Dong J, Sun ZF and Lan Q. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug]. Ai Zheng 2002; 21: 1090-1094.
-
(2002)
Ai Zheng
, vol.21
, pp. 1090-1094
-
-
Shi, M.G.1
Huang, Q.2
Dong, J.3
Sun, Z.F.4
Lan, Q.5
-
15
-
-
84862779596
-
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
-
Lu YS, Chou CH, Tzen KY, Gao M, Cheng AL, Kulp SK and Cheng JC. Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012; 83: e181-189.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
, pp. e181-189
-
-
Lu, Y.S.1
Chou, C.H.2
Tzen, K.Y.3
Gao, M.4
Cheng, A.L.5
Kulp, S.K.6
Cheng, J.C.7
-
16
-
-
80051587422
-
Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase
-
Chen CT, Yamaguchi H, Lee HJ, Du Y, Lee HH, Xia W, Yu WH, Hsu JL, Yen CJ, Sun HL, Wang Y, Yeh ET, Hortobagyi GN and Hung MC. Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase. Mol Cancer Ther 2011; 10: 1327-1336.
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 1327-1336
-
-
Chen, C.T.1
Yamaguchi, H.2
Lee, H.J.3
Du, Y.4
Lee, H.H.5
Xia, W.6
Yu, W.H.7
Hsu, J.L.8
Yen, C.J.9
Sun, H.L.10
Wang, Y.11
Yeh, E.T.12
Hortobagyi, G.N.13
Hung, M.C.14
-
17
-
-
84867434944
-
Targeting the IKKbeta/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer
-
Chen CT, Du Y, Yamaguchi H, Hsu JM, Kuo HP, Hortobagyi GN and Hung MC. Targeting the IKKbeta/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer. Mol Cancer Ther 2012; 11: 2212-2221.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 2212-2221
-
-
Chen, C.T.1
Du, Y.2
Yamaguchi, H.3
Hsu, J.M.4
Kuo, H.P.5
Hortobagyi, G.N.6
Hung, M.C.7
-
18
-
-
0013909023
-
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man
-
Freireich EJ, Gehan EA, Rall DP, Schmidt LH and Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966; 50: 219-244.
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 219-244
-
-
Freireich, E.J.1
Gehan, E.A.2
Rall, D.P.3
Schmidt, L.H.4
Skipper, H.E.5
-
19
-
-
34347215518
-
Analysis of apoptosis by propidium iodide staining and flow cytometry
-
Riccardi C and Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1: 1458-1461.
-
(2006)
Nat Protoc
, vol.1
, pp. 1458-1461
-
-
Riccardi, C.1
Nicoletti, I.2
-
20
-
-
84904653755
-
nab-Paclitaxel for the treatment of aggressive metastatic breast cancer
-
Gluck S. nab-Paclitaxel for the treatment of aggressive metastatic breast cancer. Clin Breast Cancer 2014; 14: 221-7.
-
(2014)
Clin Breast Cancer
, vol.14
, pp. 221-227
-
-
Gluck, S.1
-
21
-
-
84903714441
-
Smarter drugs emerging in pancreatic cancer therapy
-
Kleger A, Perkhofer L and Seufferlein T. Smarter drugs emerging in pancreatic cancer therapy. Ann Oncol 2014; 25: 1260-70.
-
(2014)
Ann Oncol
, vol.25
, pp. 1260-1270
-
-
Kleger, A.1
Perkhofer, L.2
Seufferlein, T.3
-
22
-
-
34347263711
-
Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models
-
Xie X, Xia W, Li Z, Kuo HP, Liu Y, Li Z, Ding Q, Zhang S, Spohn B, Yang Y, Wei Y, Lang JY, Evans DB, Chiao PJ, Abbruzzese JL and Hung MC. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 2007; 12: 52-65.
-
(2007)
Cancer Cell
, vol.12
, pp. 52-65
-
-
Xie, X.1
Xia, W.2
Li, Z.3
Kuo, H.P.4
Liu, Y.5
Li, Z.6
Ding, Q.7
Zhang, S.8
Spohn, B.9
Yang, Y.10
Wei, Y.11
Lang, J.Y.12
Evans, D.B.13
Chiao, P.J.14
Abbruzzese, J.L.15
Hung, M.C.16
-
24
-
-
34250308322
-
Apoptosis: a review of programmed cell death
-
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
-
(2007)
Toxicol Pathol
, vol.35
, pp. 495-516
-
-
Elmore, S.1
-
25
-
-
70149113223
-
Pros and cons of methods used for the prediction of oral drug absorption
-
Fotaki N. Pros and cons of methods used for the prediction of oral drug absorption. Expert Rev Clin Pharmacol 2009; 2: 195-208.
-
(2009)
Expert Rev Clin Pharmacol
, vol.2
, pp. 195-208
-
-
Fotaki, N.1
-
26
-
-
84976210826
-
Orphan Europe
-
prescribing information
-
Carbaglu. Orphan Europe 2010; prescribing information.
-
(2010)
-
-
-
27
-
-
42049085016
-
Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells
-
Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, Blanch HW and Clark DS. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog 2008; 24: 334-341.
-
(2008)
Biotechnol Prog
, vol.24
, pp. 334-341
-
-
Meadows, A.L.1
Kong, B.2
Berdichevsky, M.3
Roy, S.4
Rosiva, R.5
Blanch, H.W.6
Clark, D.S.7
|